These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31918467)

  • 1. Radiotherapy for mandibular metastases from hepatocellular carcinoma: a single institutional experience.
    Park J; Yoon SM
    Radiat Oncol J; 2019 Dec; 37(4):286-292. PubMed ID: 31918467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of mandibular dose distribution in radiotherapy for oropharyngeal cancer: dosimetric and clinical results in 18 patients.
    Jereczek-Fossa BA; Garibaldi C; Catalano G; d'Onofrio A; De Pas T; Bocci C; Ciocca M; DePaoli F; Orecchia R
    Radiother Oncol; 2003 Jan; 66(1):49-56. PubMed ID: 12559520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose radiotherapy is associated with better local control of bone metastasis from hepatocellular carcinoma.
    Jung IH; Yoon SM; Kwak J; Park JH; Song SY; Lee SW; Ahn SD; Choi EK; Kim JH
    Oncotarget; 2017 Feb; 8(9):15182-15192. PubMed ID: 28146433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy for osseous metastases from hepatocellular carcinoma: a retrospective study of 57 patients.
    Kaizu T; Karasawa K; Tanaka Y; Matuda T; Kurosaki H; Tanaka S; Kumazaki T
    Am J Gastroenterol; 1998 Nov; 93(11):2167-71. PubMed ID: 9820391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy for adrenal gland metastases from hepatocellular carcinoma.
    Yuan BY; Hu Y; Zhang L; Chen YH; Dong YY; Zeng ZC
    Clin Transl Oncol; 2017 Sep; 19(9):1154-1160. PubMed ID: 28357632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.
    He J; Zeng ZC; Tang ZY; Fan J; Zhou J; Zeng MS; Wang JH; Sun J; Chen B; Yang P; Pan BS
    Cancer; 2009 Jun; 115(12):2710-20. PubMed ID: 19382203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients.
    Zeng ZC; Tang ZY; Fan J; Qin LX; Ye SL; Zhou J; Sun HC; Wang BL; Wang JH
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1067-76. PubMed ID: 15913915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiation therapy for bone metastasis from hepatocellular carcinoma].
    Koom WS; Seong JS; Lee MJ; Park HC; Han KH; Chon JY; Moon YM; Suh CO
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):304-11. PubMed ID: 12499788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma.
    Sandroussi C; Dawson LA; Lee M; Guindi M; Fischer S; Ghanekar A; Cattral MS; McGilvray ID; Levy GA; Renner E; Greig PD; Grant DR
    Transpl Int; 2010 Mar; 23(3):299-306. PubMed ID: 19843294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of symptom and intact liver function are positive prognosticators for patients undergoing radiotherapy for lymph node metastasis from hepatocellular carcinoma.
    Kim K; Chie EK; Kim W; Kim YJ; Yoon JH; Lee HS; Ha SW
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):729-34. PubMed ID: 20171806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma Knife surgery for treating brain metastases arising from hepatocellular carcinomas.
    Park ES; Kwon DH; Park JB; Lee DH; Cho YH; Kim JH; Kim CJ
    J Neurosurg; 2014 Dec; 121 Suppl():102-9. PubMed ID: 25434943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma.
    Park J; Jung J; Kim D; Jung IH; Park JH; Kim JH; Lee SW; Yoon SM
    BMC Cancer; 2018 Oct; 18(1):1040. PubMed ID: 30367606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue.
    Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Ohtani K; Wada T
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):333-9. PubMed ID: 8567334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy for painful bone metastases from hepatocellular carcinoma.
    Seong J; Koom WS; Park HC
    Liver Int; 2005 Apr; 25(2):261-5. PubMed ID: 15780048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response relationship in local radiotherapy for hepatocellular carcinoma.
    Park HC; Seong J; Han KH; Chon CY; Moon YM; Suh CO
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):150-5. PubMed ID: 12182985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma.
    Lee E; Kim TG; Park HC; Yu JI; Lim DH; Nam H; Lee H; Lee JH
    Radiat Oncol J; 2015 Sep; 33(3):217-25. PubMed ID: 26484305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metastasis from hepatocellular carcinoma: The impact of radiotherapy on control of intracranial hemorrhage.
    Yamakawa Y; Moriguchi M; Aramaki T; Mitsuya K; Asakura K; Sawada A; Endo M; Nakasu Y
    Hepatol Res; 2015 Nov; 45(11):1071-5. PubMed ID: 25470452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/advanced hepatocellular carcinoma?
    Jiang W; Zeng ZC
    Oncology; 2013; 84 Suppl 1():69-74. PubMed ID: 23428862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients.
    Lee IJ; Koom WS; Lee CG; Kim YB; Yoo SW; Keum KC; Kim GE; Choi EC; Cha IH
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1084-91. PubMed ID: 19327914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abscopal complete regression of hepatocellular carcinoma with multiple pleural metastases.
    Ohmatsu K; Hashimoto Y; Kawanishi M; Ishii Y; Kono S; Kuribayashi S; Ariizumi S; Karasawa K
    Int Cancer Conf J; 2021 Jan; 10(1):54-58. PubMed ID: 33489702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.